Trial Site Detail


Imatinib + Selinexor
Selinexor in Combination With Imatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors. (SeliGIST)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting


Hospital Virgen del Rocio

Sevilla , 41013


Principal Investigator:
Javier Martín Broto, MD
Laura Bernal, SC 671 533 319
Activation Status of this Site:
Notes about this Site:
Hospital Virgen del Rocio Website:



Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.